Sign up to save your podcasts
Or
Share Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discuss approved and novel treatment approaches for ER-positive metastatic breast cancer that has progressed on prior CDK4/6 inhibitor therapy.
View all episodes
By Dr. Neil Love
4.4
6363 ratings
Dr Aditya Bardia from Massachusetts General Hospital in Boston, Massachusetts, and Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville, Tennessee, discuss approved and novel treatment approaches for ER-positive metastatic breast cancer that has progressed on prior CDK4/6 inhibitor therapy.
More shows like Breast Cancer Update
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
317 Listeners
JAMA Clinical Reviews
497 Listeners
Lung Cancer Update
31 Listeners
Hematologic Oncology Update
73 Listeners
Prostate Cancer Update
14 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
120 Listeners
Breastcancer.org Podcast
44 Listeners
ASCO Daily News
58 Listeners
The Curbsiders Internal Medicine Podcast
3,348 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
ASCO Guidelines
45 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
368 Listeners
Oncology Today with Dr Neil Love
57 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners